Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun:150:44-52.
doi: 10.1016/j.neurobiolaging.2025.03.002. Epub 2025 Mar 3.

White matter hyperintensities in dementia with lewy bodies and posterior cortical atrophy

Affiliations

White matter hyperintensities in dementia with lewy bodies and posterior cortical atrophy

Neha Singh-Reilly et al. Neurobiol Aging. 2025 Jun.

Abstract

Dementia with Lewy bodies (DLB) and posterior cortical atrophy (PCA) are neurodegenerative disorders that can overlap clinically and in patterns of regional hypometabolism and show elevated white matter hyperintensity (WMH) burden. Little is known about the regional WMH burden in DLB patients without any interference of AD pathology and how these patterns compare to PCA patients. Twenty-two amyloid-negative DLB patients, 40 amyloid-positive PCA patients, and 49 amyloid-negative cognitively unimpaired (CU) healthy individuals were recruited at Mayo Clinic, Rochester, MN. They underwent a 3 T head MRI, a Pittsburgh Compound B (PiB) PET scan, and a fluid-attenuated inversion recovery scan (FLAIR). The relationship between regional WMH volume and diagnosis was evaluated while adjusting for age and sex. DLB showed greater periventricular WMH burden in the temporal, occipital, and frontal lobes and greater WMH burden in the posterior corpus callosum compared to CU. PCA showed greater subcortical WMH burden in temporal, parietal, and occipital lobes, and greater periventricular WMH burden in the temporal, occipital, and frontal lobes, compared to CU. On comparing both dementia groups, PCA showed greater subcortical WMH burden in the temporal and occipital lobes compared to DLB, while DLB showed greater WMH burden in the posterior corpus callosum compared to PCA. Hence, DLB and PCA are both associated with periventricular WMHs, with deep subcortical WMHs being more characteristic of PCA, and callosal WMHs more characteristic of Aβ-negative DLB patients, suggesting different pathophysiological mechanisms underlying the development of WMHs in these two neurodegenerative diseases.

Keywords: Dementia with Lewy bodies; Posterior cortical atrophy; White matter hyperintensities.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Jennifer L. Whitwell reports financial support was provided by National Institutes of Health. Kejal Kantarci reports financial support was provided by National Institutes of Health. Ronald C. Petersen reports financial support was provided by National Institutes of Health. Keith A. Josephs reports a relationship with National Institutes of Health that includes: funding grants. Mary M. Machulda reports a relationship with National Institutes of Health that includes: funding grants. Kejal Kantarci reports a relationship with National Institutes of Health that includes: funding grants. Jennifer L. Whitwell reports a relationship with National Institutes of Health that includes: funding grants. Jonathan Graff-Radford reports a relationship with National Institutes of Health that includes: funding grants. Matthew L. Senjem reports a relationship with Parexel International that includes: equity or stocks. Matthew L. Senjem reports a relationship with Gilead Sciences Inc that includes: equity or stocks. Matthew L. Senjem reports a relationship with Inovio Pharmaceuticals Inc that includes: equity or stocks. Matthew L. Senjem reports a relationship with Medtronic that includes: equity or stocks. Matthew L. Senjem reports a relationship with Oncothyreon Inc that includes: equity or stocks. Ronald C. Petersen reports a relationship with National Institutes of Health that includes: funding grants. Val J. Lowe reports a relationship with Bayer Schering Pharma AG that includes: consulting or advisory. Val J. Lowe reports a relationship with Eisai Inc that includes: consulting or advisory. Val J. Lowe reports a relationship with Avid Radiopharmaceuticals Inc that includes: consulting or advisory and funding grants. Val J. Lowe reports a relationship with Merck Research that includes: consulting or advisory. Val J. Lowe reports a relationship with GE Healthcare that includes: funding grants. Val J. Lowe reports a relationship with SIEMENS that includes: funding grants. Val J. Lowe reports a relationship with National Institutes of Health that includes: funding grants. Bradley F. Boeve reports a relationship with GE Healthcare that includes: consulting or advisory. Bradley F. Boeve reports a relationship with Myriad Genetics Inc that includes: funding grants. Bradley F. Boeve reports a relationship with National Institutes of Health that includes: funding grants. Bradley F. Boeve reports a relationship with Alzheimer’s Association that includes: funding grants. Clifford R. Jack reports a relationship with National Institutes of Health that includes: funding grants. Clifford R. Jack reports a relationship with GHR Foundation that includes: funding grants. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. American Academy of Sleep Medicine., 2005. The international classification of sleep disorders : diagnostic and coding manual, 2nd ed. American Academy of Sleep Medicine, Westchester, Ill.
    1. Armstrong NJ, Mather KA, Sargurupremraj M, Knol MJ, Malik R, Satizabal CL, Yanek LR, Wen W, Gudnason VG, Dueker ND, Elliott LT, Hofer E, Bis J, Jahanshad N, Li S, Logue MA, Luciano M, Scholz M, Smith AV, Trompet S, Vojinovic D, Xia R, Alfaro-Almagro F, Ames D, Amin N, Amouyel P, Beiser AS, Brodaty H, Deary IJ, Fennema-Notestine C, Gampawar PG, Gottesman R, Griffanti L, Jack CR Jr., Jenkinson M, Jiang J, Kral BG, Kwok JB, Lampe L, D CML, Maillard P, Marchini J, Bastin ME, Mazoyer B, Pirpamer L, Rafael Romero J, Roshchupkin GV, Schofield PR, Schroeter ML, Stott DJ, Thalamuthu A, Trollor J, Tzourio C, van der Grond J, Vernooij MW, Witte VA, Wright MJ, Yang Q, Morris Z, Siggurdsson S, Psaty B, Villringer A, Schmidt H, Haberg AK, van Duijn CM, Jukema JW, Dichgans M, Sacco RL, Wright CB, Kremen WS, Becker LC, Thompson PM, Mosley TH, Wardlaw JM, Ikram MA, Adams HHH, Seshadri S, Sachdev PS, Smith SM, Launer L, Longstreth W, DeCarli C, Schmidt R, Fornage M, Debette S, Nyquist PA, 2020. Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities. Stroke 51(7), 2111–2121.10.1161/STROKEAHA.119.027544 - DOI - PMC - PubMed
    1. Ashburner J, Friston KJ, 2005. Unified segmentation. Neuroimage 26(3), 839–851.10.1016/j.neuroimage.2005.02.018 - DOI - PubMed
    1. Avants BB, Epstein CL, Grossman M, Gee JC, 2008. Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal 12(1), 26–41.10.1016/j.media.2007.06.004 - DOI - PMC - PubMed
    1. Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, Perry R, O’Brien J, 1999. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 67(1), 66–72.10.1136/jnnp.67.1.66 - DOI - PMC - PubMed

Publication types